Manufacturing and marketing of diagnostic reagents and medical devices in the healthcare sector.
Annual revenue $112,455 Latest available
Total funding - Funding intelligence
Employees 2 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Pathozyme Diagnostics

Pathozyme Diagnostics is a company. The company has 2 employees as of April 06, 2024. Pathozyme Diagnostics offers products and services including Clinical Chemistry Reagents and Serology Reagents.

  • Employees 2 as on 06 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Oxalis Diagnostics Pvt. Ltd
  • Jurisdiction Kolhapur, Maharashtra, India
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $112.45 K (USD)
    56.76
    as on Mar 31, 2021
  • Net Profit
    $1.76 K (USD)
    55.79
    as on Mar 31, 2021
  • EBITDA
    $16.75 K (USD)
    299.24
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    2

    as on Apr 06, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Pathozyme Diagnostics

Pathozyme Diagnostics offers a comprehensive portfolio of products and services, including Clinical Chemistry Reagents and Serology Reagents.

Product name locked
Category locked
Primary

Clinical chemistry reagents are manufactured for diagnostic laboratories, ensuring they perform according to international standards.

Product name locked
Category locked
Locked

Serology reagents are developed for various immunoassay applications, contributing to improved healthcare outcomes.

Funding Insights of Pathozyme Diagnostics

Premium access

Detailed funding history for Pathozyme Diagnostics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Pathozyme Diagnostics

Investments
Premium access

Investment portfolio details for Pathozyme Diagnostics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Pathozyme Diagnostics

Premium access

Detailed financials for Pathozyme Diagnostics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Pathozyme Diagnostics Comparisons

Pathozyme Diagnostics Primary company
Description
Manufacturing and marketing of diagnostic reagents and medic...
Location
-
Founded Year
-
Annual Revenue
$112.45 K (USD)
Net Profit
$1.76 K (USD)
EBITDA
$16.75 K (USD)
Employees
2
As of 2024
Premium access

Peer comparison for Pathozyme Diagnostics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Pathozyme Diagnostics

Premium access

Detailed competitors of Pathozyme Diagnostics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Pathozyme Diagnostics

Premium access

Complete news archive for Pathozyme Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pathozyme Diagnostics

As of Apr 06, 2024, the latest employee count at Pathozyme Diagnostics is 2.

Annual revenue of Pathozyme Diagnostics is $112.45K as on Mar 31, 2021.

Pathozyme Diagnostics is recognized as a leading provider of healthcare solutions, having been established in 2006 to focus on the innovation and development of medical devices and reagents. It is noted for manufacturing clinical chemistry, serology, and protein immunoassay reagents that adhere to international standards through rigorous quality assurance protocols. Commitments to RD, process validation, and certifications like ISO 9001:2015 and ISO 13485:2016 are maintained to enhance quality of life and reduce human suffering. Participation in external quality assurance programs ensures customer satisfaction, while a positive work environment is fostered for employees.

Pathozyme Diagnostics offers Clinical Chemistry Reagents and Serology Reagents.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available